Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis
Oncotarget
.
2019 Jan 11;10(4):558.
doi: 10.18632/oncotarget.26597.
Authors
Arivajiagane Arundhathi
#
1
2
,
Wen-Han Chuang
#
1
,
Jen-Kun Chen
#
3
,
Shin-E Wang
#
4
,
Yi-Ming Shyr
4
,
Jiun-Yu Chen
3
,
Wei-Neng Liao
3
,
Hsin-Wei Chen
1
,
Yi-Min Teng
1
,
Chiao-Chih Pai
1
,
Chih-Hong Wang
1
Affiliations
1
Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
2
Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu, Taiwan.
3
Institute of Biomedical Engineering & Nanomedicine, National Health Research Institutes, Miaoli, Taiwan.
4
Department of General Surgery, Taipei Veterans General Hospital, and National Yang Ming University, Taipei, Taiwan.
#
Contributed equally.
PMID:
30728905
PMCID:
PMC6355182
DOI:
10.18632/oncotarget.26597
Abstract
[This corrects the article DOI: 10.18632/oncotarget.10583.].
Publication types
Published Erratum